PROMENXANA financials
A multi-period view of the public annual-account figures reported for PROMENXANA, with comparable measures and links to available source documents.
Company overviewRegistry number
0635977332
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for PROMENXANA
2025 versus 2024
- Operating line
- €20,595
- EBITDA
- €19,900
- Total assets
- €94,847
- Equity
- €44,954
-58.6%
-57.7%
-38%
-8.2%
EBITDA margin +96.6% · Equity ratio +47.4%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.